Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247331 | SCV000305397 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000247331 | SCV000528007 | benign | not specified | 2017-01-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000528226 | SCV000626731 | benign | Glycogen storage disease type III | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000528226 | SCV001254963 | uncertain significance | Glycogen storage disease type III | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV000528226 | SCV002055546 | benign | Glycogen storage disease type III | 2021-07-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003114419 | SCV003799858 | benign | not provided | 2023-09-22 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000528226 | SCV002094543 | likely benign | Glycogen storage disease type III | 2019-12-02 | no assertion criteria provided | clinical testing |